Cosmos Health Inc. (NASDAQ:COSM) Short Interest Down 19.5% in March

Cosmos Health Inc. (NASDAQ:COSM) was the recipient of a large decrease in short interest during the month of March. As of March 15th, there was short interest totalling 646,900 shares, a decrease of 19.5% from the February 28th total of 804,000 shares. Based on an average daily volume of 414,400 shares, the days-to-cover ratio is presently 1.6 days. Currently, 4.0% of the shares of the company are short sold.

Cosmos Health Price Performance

Shares of COSM stock opened at $0.43 on Wednesday. Cosmos Health has a 52-week low of $0.35 and a 52-week high of $1.58. The stock has a 50 day moving average price of $0.59 and a 200 day moving average price of $0.70. The firm has a market capitalization of $9.93 million, a P/E ratio of -0.17 and a beta of 5.60. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.24 and a current ratio of 1.44.

Insider Activity

In other news, CEO Grigorios Siokas purchased 62,500 shares of the business’s stock in a transaction on Wednesday, January 15th. The stock was acquired at an average price of $0.80 per share, for a total transaction of $50,000.00. Following the acquisition, the chief executive officer now directly owns 4,087,727 shares of the company’s stock, valued at $3,270,181.60. This represents a 1.55 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders acquired 832,506 shares of company stock valued at $502,164 in the last quarter. 15.61% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Cosmos Health

A hedge fund recently raised its stake in Cosmos Health stock. Geode Capital Management LLC lifted its stake in Cosmos Health Inc. (NASDAQ:COSM) by 29.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 193,432 shares of the company’s stock after purchasing an additional 43,704 shares during the quarter. Geode Capital Management LLC owned about 0.83% of Cosmos Health worth $129,000 as of its most recent SEC filing. 12.61% of the stock is owned by institutional investors.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.